BD MAX CTGCTV2, BD MAX System

FDA 510(k) K182692 · Becton, Dickinson and Company

Substantially Equivalent

510(k) numberK182692

Submission

Device name
BD MAX CTGCTV2, BD MAX System
Applicant
Becton, Dickinson and Company
Sparks, MD, US
Received
September 27, 2018
Decision date
January 8, 2019
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
OUY – Trichomonas Vaginalis Nucleic Acid Amplification Test System
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3860
Specialty
Immunology

In vitro nucleic acid amplification test for the qualitative detection of ribosomal rna from trichomonas vaginalis as an aid in the diagnosis of trichomoniasis from vaginal, cervical, urogenital and gynecological specimens from symptomatic patients

Other 510(k)s with product code OUY

510(k)DeviceApplicantDecision
K231316Aptima Trichomonas vaginalis AssayOUY · Traditional Hologic, Inc.11/06/2023SE
K151589BD Max Ct/Gc/Tv, BD Max InstrumentOUY · Traditional Becton, Dickinson and Company09/06/2016SE
K161619Xpert TV, Xpert Urine Specimen Collection Kit, GeneXpert Dx Systems (GX-I, GX-II, GX-IV…OUY · Traditional Cepheid08/29/2016SE
K161182Solana Trichomonas AssayOUY · Traditional Quidel Corporation08/15/2016SE
K151565Xpert® TV Assay on the Cepheid GeneXpert Instrument Systems (GeneXpert Dx, GeneXpert…OUY · Traditional Cepheid10/16/2015SE
K143329AmpliVue Trichomonas AssayOUY · Traditional Quidel Corporation03/17/2015SE
K130268BD Probetec Trichomonas Vaginalis (TV) QX Amplified DNA AssayOUY · Traditional Becton, Dickinson & CO08/23/2013SE
K122062Aptima Trichomonas Vaginalis Assay - PantherOUY · Traditional Gen-Probe, Inc.01/09/2013SE

More from Gen-Probe, Inc.

510(k)DeviceDecision
K260128BD Preset™ and BD A-Line™ Arterial Blood Collection SyringesJKA · Special 04/15/2026SE
K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood…JKA · Traditional 04/10/2026SE
K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood…JKA · Traditional 04/10/2026SE
K260184Onclarity™ Self-Collection KitSEP · Traditional 04/02/2026SE
K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood…JKA · Traditional 03/13/2026SE
K2508840.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP SyringeNGT · Traditional 12/02/2025SE
K250358BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR…PCI · Traditional 10/31/2025SE
K250059BD PhaSeal™ Optima Connecting Set (C83-O); BD PhaSeal™ Optima Spike Set (C180-O)ONB · Traditional 09/12/2025SE
K251713BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)LON · Traditional 08/08/2025SE
K251350BD Plastipak™ SyringeFMF · Traditional 07/29/2025SE

Questions and answers

When was BD MAX CTGCTV2, BD MAX System cleared by the FDA?

BD MAX CTGCTV2, BD MAX System (K182692) received a 510(k) decision of Substantially Equivalent on January 8, 2019, 103 days after the submission was received.

What is the product code of K182692?

The FDA product code is OUY – Trichomonas Vaginalis Nucleic Acid Amplification Test System, a Class II (moderate risk) device regulated under 21 CFR 866.3860.